Diffuse idiopathic skeletal hyperostosis: Clinical features and pathogenic mechanisms

Nature Reviews Rheumatology

Volumn 9, Issue 12, 2013, Pages 741-750

  Mader, Reuven ^a   Verlaan, Jorrit Jan ^b   Buskila, Dan ^c  

^a HAEMEK MEDICAL CENTER   (Israel)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIVITAMIN K; BETA CATENIN; BONE MORPHOGENETIC PROTEIN 2; CAPSAICIN; COLLAGEN TYPE 6; CORTICOSTEROID; ENDOTHELIN 1; GROWTH HORMONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NONSTEROID ANTIINFLAMMATORY AGENT; PLATELET DERIVED GROWTH FACTOR BB; PROSTACYCLIN; RETINOL; SOMATOMEDIN C; TRAMADOL; TRANSFORMING GROWTH FACTOR BETA1; WNT PROTEIN;

ANKYLOSING HYPEROSTOSIS; ANKYLOSING SPONDYLITIS; CLINICAL FEATURE; COMORBIDITY; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; ENTHESOPATHY; GENETIC VARIABILITY; HEREDITY; HETEROTOPIC OSSIFICATION; HUMAN; HYPERTHERMIC THERAPY; KINESIOTHERAPY; LIGAMENT CALCINOSIS; LIMITED MOBILITY; METABOLIC DISORDER; MORNING STIFFNESS; OSTEOARTHRITIS; PATHOGENICITY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SPINAL PAIN; SPINE FRACTURE; SPINE SURGERY; SPONDYLOSIS; WEIGHT REDUCTION;

HUMANS; HYPEROSTOSIS, DIFFUSE IDIOPATHIC SKELETAL; OSSIFICATION, HETEROTOPIC;

EID: 84891149883     PISSN: 17594790     EISSN: 17594804     Source Type: Journal    
DOI: 10.1038/nrrheum.2013.165     Document Type: Review

References (107)

1. Forestier, J. & Rotes-Querol, J. Senile ankylosing hyperostosis of the spine. Ann. Rheum. Dis. 9, 321-330 (1950).
2. Van der Merwe, A. E., Maat, G. J. & Watt, I. Diffuse idiopathic skeletal hyperostosis: Diagnosis in a palaeopathological context. Homo 63, 202-215 (2012).
3. Resnick, D. & Niwayama, G. Radiographic and pathologic features of spinal involvement in diffuse idiopathic skeletal hyperostosis (DISH). Radiology 119, 559-568 (1976).
4. Beyeler, C. et al. Diffuse idiopathic skeletal hyperostosis (DISH) of the elbow: A cause of elbow pain? A controlled study. Br. J. Rheumatol. 31, 319-323 (1992).
5. Mader, R., Novofestovski, I., Adawi, M. & Lavi, I. Metabolic syndrome and cardiovascular risk in patients with diffuse idiopathic skeletal hyperostosis. Semin. Arthritis Rheum. 38, 361-365 (2009).
6. Mader, R. et al. Extraspinal manifestations of diffuse idiopathic skeletal hyperostosis. Rheumatology 48, 1478-1481 (2009).
7. Verlaan, J. J., Boswijk, F. L., de Ru, J. A., Dhert, W. J. & Oner, F. C. Diffuse idiopathic skeletal hyperostosis of the cervical spine: An underestimated cause of dysphagia and airway obstraction. Spine J. 11, 1058-1067 (2011).
8. Weisz, G. M., Matucci-Cerinic, M., Lippi, D. & Albury, W. R. The ossification diathesis in the medici family: DISH and other features. Rheumatol. Int. 31, 1649-1652 (2011).
9. Verlaan, J. J., Oner, F. C. & Maat, G. J. Diffuse idiopathic skeletal hyperostosis in ancient clergymen. Eur. Spine J. 16, 1129-1135 (2007). (Pubitemid 350104615)
10. Chhem, R. K., Schmit, P. & Fauré, C. Did Ramesses II really have ankylosing spondylitis? A reappraisal. Can. Assoc. Radiol. J. 55, 211-217 (2004). (Pubitemid 39361358)
11. Crubézy, E. & Trinkaus, E. Shanidar 1: A case of hyperostotic disease (DISH) in the middle Paleolithic. Am. J. Phys. Anthropol. 89, 411-420 (1992).
12. Giuffra, V. et al. Diffuse idiopathic skeletal hyperostosis in the Medici, Grand Dukes of Florence (XVI century). Eur. Spine J. 19 (Suppl. 2), S103-S107 (2010).
13. Waldron, T. DISH at merton priory: Evidence for a "new" occupational disease? BMJ 291, 1762-1763 (1985). (Pubitemid 16161794)
14. Rogers, J. & Waldron, T. DISH and the monastic way of life. Int. J. Osteoarchaeol. 11, 357-365 (2001). (Pubitemid 33602994)
15. Ullrich, H. [Goethe's skull and skeleton] 60, 341-368 (2002).
16. Kiss, C. et al. Prevalence of diffuse idiopathic skeletal hyperostosis in Budapest, Hungary. Rheumatology (Oxford) 41, 1335-1336 (2002). (Pubitemid 35363815)
17. Westerveld, L. A., van Ufford, H. M., Verlaan, J. J. & Oner, F. C. The prevalence of diffuse idiopathic skeletal hyperostosis in an outpatient population in the Netherlands. J. Rheumatol. 35, 1635-1638 (2008).
18. Weinfeld, R. M., Olson, P. N., Maki, D. D. & Griffiths, H. J. The prevalence of diffuse idiopathic skeletal hyperostosis (DISH) in two large american midwest metropolitan hospital populations. Skeletal Radiol. 26, 222-225 (1997). (Pubitemid 27197060)
19. Holton, K. F. et al. Diffuse idiopathic skeletal hyperostosis and its relation to back pain among older men: The MrOS study. Semin. Arthritis Rheum. 41, 131-138 (2011).
20. Bray, G. A. & Bellanger, T. Epidemiology, trends, and morbidities of obesity and the metabolic syndrome. Endocrine 29, 109-117 (2006). (Pubitemid 43780352)
21. Mader, R. & Lavi, I. Diabetes mellitus and hypertension as risk factors for early diffuse idiopathic skeletal hyperostosis (DISH). Osteoarthritis Cartilage 17, 825-828 (2009).
22. Mader, R. Diffuse idiopathic skeletal hyperostosis: A distinct clinical entity. Isr. Med. Assoc. J. 5, 506-508 (2003). (Pubitemid 36992233)
23. Fornasier, V. L., Littlejohn, G. O., Urowitz, M. B., Keystone, E. C. & Smythe, H. A. Spinal entheseal new bone formation: The early changes of spinal diffuse idiopathic skeletal hyperostosis. J. Rheumatol. 10, 934-947 (1983).
24. Belanger, T. A. & Rowe, D. E. Diffuse idiopathic skeletal hyperostosis: Musculoskeletal manifestations. J. Am. Acad. Orthop. Surg. 9, 258-267 (2001).
25. Mader, R. Clinical manifestations of diffuse idiopathic skeletal hyperostosis of the cervical spine. Semin. Arthritis Rheum. 32, 130-135 (2002). (Pubitemid 35351248)
26. Di Girolamo, C. et al. Intervertebral disc lesions in diffuse idiopathic skeletal hyperostosis (DISH). Clin. Exp. Rheumatol. 19, 310-312 (2001).
27. Hutton, C. DISH. a state not a disease? [editorial]. Br. J. Rheumatol. 28, 277-280 (1989).
28. Utsinger, P. D. Diffuse idiopathic skeletal hyperostosis. Clin. Rheum. Dis. 11, 325-351 (1985). (Pubitemid 15005943)
29. Resnick, D. et al. Diffuse idiopathic skeletal hyperostosis (DISH) [ankylosing hyperostosis of Forestier and Rotes-Querol]. Semin. Arthritis Rheum. 7, 153-187 (1978).
30. Mata, S. et al. A controlled study of diffuse idiopathic skeletal hyperostosis. Clinical features and functional status. Medicine 76, 104-117 (1997). (Pubitemid 27157665)
31. Schlapbach, P. et al. Diffuse idiopathic skeletal hyperostosis (DISH) of the spine: A cause of back pain? A controlled study. Br. J. Rheumatol. 28, 299-303 (1989). (Pubitemid 19205923)
32. Mader, R. et al. Non articular tenderness and functional status in patients with diffuse idiopathic skeletal hyperostosis. J. Rheumatol. 37, 1911-1916 (2010).
33. Olivieri, I. et al. Diffuse idiopathic skeletal hyperostosis may give the typical postural abnormalities of advanced ankylosing spondylitis. Rheumatology 46, 1709-1711 (2007). (Pubitemid 350018494)
34. Baraliakos, X., Listing, J., Buschmann, J., von der Recke, A. & Braun, J. A comparison of new bone formation in patients with ankylosing spondylitis and patients with diffuse idiopathic skeletal hyperostosis. A retrospective cohort study over six years. Arthritis Rheum. 64, 1127-1133 (2012).
35. Belanger, T. A. & Rowe, D. E. Diffuse idiopathic skeletal hyperostosis: Musculoskeletal manifestations. J. Am. Acad. Orthop. Surg. 9, 258-267 (2001).
36. Laroche, M. et al. Lumbar and cervical stenosis. Frequency of the association, role of the ankylosing hyperostosis. Clin. Rheumatol. 11, 533-535 (1992). (Pubitemid 23028034)
37. Liu, P. et al. Spinal trauma in mainland China from 2001 to 2007: An epidemiological study based on a nationwide database. Spine (Phila Pa 1976) 37, 1310-1315 (2012).
38. Caron, T. et al. Spine fractures in patients with ankylosing spinal disorders. Spine (Phila Pa 1976) 35, E458-E464 (2010).
39. Westerveld, L. A., Verlaan, J. J. & Oner, F. C. Spinal fractures in patients with ankylosing spinal disorders: A systematic review of the literature on treatment, neurological status and complications. Eur. Spine J. 18, 145-156 (2009).
40. Whang, P. G. et al. The management of spinal injuries in patients with ankylosing spondylitis or diffuse idiopathic skeletal hyperostosis: A comparison of treatment methods and clinical outcomes. J. Spinal Disord. Tech. 22, 77-85 (2009).
41. Westerveld, L. A., van Bemmel, J. C., Dhert, W. J., Oner, F. C. & Verlaan, J. J. Clinical outcome after traumatic spinal fractures in patients with ankylosing spinal disorders compared with control patients. Spine J. http://www.doi.org/10.1016/j.spinee.2013.06.038.
42. Littlejohn, J. O., Urowitz, M. B., Smythe, H. A. & Keystone, E. C. Radiographic features of the hand in diffuse idiopathic skeletal hyperostosis (DISH). Radiology 140, 623-629 (1981).
43. Beyeler, C. et al. Diffuse idiopathic skeletal hyperostosis (DISH) of the shoulder. A cause of shoulder pain? Br. J. Rheumatol. 29, 349-353 (1990). (Pubitemid 20338053)
44. Utsinger, P. D., Resnick, D. & Shapiro, R. Diffuse skeletal abnormalities in Forestier's disease. Arch. Intern. Med. 136, 763-768 (1976).
45. Schlapbach, P. et al. The prevalence of palpable finger joints nodules in diffuse idiopathic skeletal hyperostosis (DISH). A controlled study. Br. J. Rheumatol. 31, 531-534 (1992).
46. Littlejohn, J. O. & Urowitz, M. B. Peripheral enthesopathy in diffuse idiopathic skeletal hyperostosis (DISH): A radiologic study. J. Rheumatol. 9, 568-572 (1982). (Pubitemid 13205174)
47. Resnick, D., Shaul, S. R. & Robins, J. M. Diffuse idiopathic skeletal hyperostosis (DISH): Forestier's disease with extraspinal manifestations. Radiology 115, 513-524 (1975).
48. Haller, J. et al. Diffuse idiopathic skeletal hyperostosis: Diagnostic significance of radiographic abnormalities of the pelvis. Radiology 172, 835-839 (1989). (Pubitemid 19211615)
49. Shehab, D., Elgazzar, A. H. & Collier, B. D. Heterotopic ossification. J. Nucl. Med. 43, 346-353 (2002). (Pubitemid 34208096)
50. Gorman, C., Jawad, A. S. M. & Chikanza, I. A family with diffuse idiopathic hyperostosis. Ann. Rheum. Dis. 64, 1794-1795 (2005).
51. Burges-Armas, J. et al. Ectopic calcification among families in the Azores: Clinical and radiological manifestations in families with diffuse idiopathic skeletal hyperostosis and chondrocalcinosis. Arthritis Rheum. 54, 1340-1349 (2006).
52. Kranenburg, H. C. et al. The dog as an animal model for DISH? Eur. Spine J. 19, 1325-1329 (2010).
53. Havelka, S. et al. Are DISH and OPLL genetically related? Ann. Rheum. Dis. 60, 902-903 (2001). (Pubitemid 32778191)
54. Tsukahara, S. et al. COL6A1, the candidate gene for ossification of the posterior longitudinal ligament, is associated with diffuse idiopathic skeletal hyperostosis in Japanese. Spine 30, 2321-2324 (2005). (Pubitemid 41504903)
55. Shingyouchi, O., Nagahama, A. & Niida, M. Ligamentous ossification of the cervical spine in the late middle-aged Japanese men. Its relation to body mass index and glucose metabolism. Spine 21, 2474-2478 (1996). (Pubitemid 26403463)
56. Littlejohn, G. O. Insulin and new bone formation in diffuse idiopathic skeletal hyperostosis. Clin. Rheumatol. 4, 294-300 (1985). (Pubitemid 16243504)
57. Denko, C. W., Boja, B. & Moskowitz, R. W. Growth promoting peptides in osteoarthritis and diffuse idiopathic skeletal hyperostosis - insulin, insulin-like growth factor I, growth hormone. J. Rheumatol. 21, 1725-1730 (1994). (Pubitemid 24285491)
58. Vezyroglou, G., Mitropoulos, A., Kyriazis, N. & Antoniadis, C. A metabolic syndrome in diffuse idiopathic skeletal hyperostos: A controlled study. J. Rheumatol. 23, 672-676 (1996). (Pubitemid 26132852)
59. Akune, T. et al. Insulin secretory response is positively associated with the extent of ossification of the posterior longitudinal ligament of the spine. J. Bone Joint Surg. 83A, 1537-1544 (2001). (Pubitemid 32953353)
60. Kiss, C., Szilagyi, M., Paksy, A. & Poor, G. Risk factors for diffuse idiopathic skeletal hyperostosis: A case control study. Rheumatology (Oxford) 41, 27-30 (2002). (Pubitemid 34537917)
61. Sarzi-Puttini, P. & Atzeni, F. New developments in our understanding of DISH (diffuse idiopathic skeletal hyperostosis). Curr. Opin. Rheumatol. 16, 287-292 (2004). (Pubitemid 38541510)
62. Miyazawa, N. & Akiyama, I. Diffuse idiopathic skeletal hyperostosis associated with risk factors for stroke. Spine 31, E225-E229 (2006).
63. Forestier, J. & Lagier, R. Ankylosing hyperostosis of the spine. Clin. Orthop. 74, 65-83 (1971).
64. Sencan, D., Elden, H., Nacitrahan, V., Sencan, M. & Kaptanoglu, E. The prevalence of diffuse idiopathic skeletal hyperostosis in patients with diabetes mellitus. Rheumatol. Int. 25, 518-521 (2005). (Pubitemid 41355568)
65. Denko, C. W. & Malemud, C. J. Body mass index and blood glucose: Correlations with serum insulin, growth hormone, and insulin-like growth factor 1 levels in patients with diffuse idiopathic skeletal hyperostosis (DISH). Rheumatol. Int. 26, 292-297 (2006). (Pubitemid 43097522)
66. Littlejohn, G. O. & Smythe, H. A. Marked hyperinsulinemia after glucose challenge in patients with diffuse idiopathic skeletal hyperostosis. J. Rheumatol. 8, 965-968 (1981). (Pubitemid 12122010)
67. Eckertova, M. et al. Impaired insulin secretion and uptake in patients with diffuse idiopathic skeletal hyperostosis. Endocr. Regul. 43, 149-155 (2009).
68. Mueller, M. B. et al. Insulin is essential for in vitro chondrogenesis of mesenchymal progenitor cells and influences chondrogenesis in a dose-dependent manner. Int. Orthop. 37, 153-158 (2013).
69. Ohlsson, C., Bengtsson, B. A., Isaksson, O. G. P., Andereassen, T. T. & Slootweg, M. C. Growth hormone and bone. Endocrine Rev. 19, 55-79 (1998). (Pubitemid 29122074)
70. Vetter, U. et al. Human fetal and adult chondrocytes. Effect of insulinlike growth factors I and II, insulin, and growth hormone on clonal growth. J. Clin. Invest. 77, 1903-1908 (1986). (Pubitemid 16062646)
71. Denko, C. W., Boja, B. & Moskowitz, R. W. Growth factors, insulin-like growth factor 1 and growth hormone, in synovial fluid and serum of patients with rheumatic disorders. Osteoarthritis Cartilage 4, 245-249 (1996). (Pubitemid 26408293)
72. Denko, C. W., Boja, B. & Malemud, C. J. Intra-erythrocyte deposition of growth hormone in rheumatic diseases. Rheumatol. Int. 23, 11-14 (2003). (Pubitemid 36207851)
73. el Miedany, Y. M., Wassif, G. & el Baddini, M. Diffuse idiopathic skeletal hyperostosis (DISH): Is it of vascular etiology? Clin. Exp. Rheumatol. 18, 193-200 (2000). (Pubitemid 30208263)
74. Nesher, G. & Zuckner, J. Rheumatologic complications of vitamin A and retinoids. Semin. Arthritis Rheum. 24, 291-296 (1995).
75. Abiteboul, M., Arlet J., Sarrabay, M. A., Mazières, B. & Thouvenot, J. P. Etude du metabolisme de la vitamine A au cours de la maladie hyperostosique de Forestier et Rote's-Querol. Rev. Rhum. Ed. Fr. 53, 143-145 (1986). (Pubitemid 16166431)
76. Ling, T. C., Parkin, G., Islam, J., Seukeran, D. C. & Cunliffe, W. J. What is the cumulative effect of long-term, low dose isotretinoin on the development of DISH? Br. J. Dermatol. 144, 630-632 (2001). (Pubitemid 32232030)
77. Aeberli, D., Schett, G., Eser, P., Seitz, M. & Villiger, P. M. Serum Dkk 1 levels of DISH patients are not different from healthy controls. Joint Bone Spine 78, 422-423 (2011).
78. Daoussis, D. & Andonopoulos, A. P. The emerging role of Dickkopf 1 in bone biology: Is it the main switch controlling bone and joint remodeling? Semin. Arthritis Rheum. 41, 170-177 (2011).
79. Senolt, L. et al. Low circulating Dickkopf 1 and its link with severity of spinal involvement in diffuse idiopathic skeletal hyperostosis. Ann. Rheum. Dis. 71, 71-74 (2012).
80. Mader, R. & Verlaan, J. J. Bone: Exploring factors responsible for bone formation in DISH. Nat. Rev. Rheumatol. 8, 10-12 (2011).
81. Kosaka, T., Imakiire, A., Mizuno, F. & Yamamoto, K. Activation of nuclear factor κB at the onset of ossification of the spinal ligaments. J. Orthop. Sci. 5, 572-578 (2000). (Pubitemid 32016266)
82. Inaba, T. et al. Enhanced expression of platelet-derived growth factor-β receptor by high glucose. Involvement of platelet-derived growth factor in diabetic angiopathy. Diabetes 45, 507-512 (1996). (Pubitemid 26110258)
83. Pfeiffer, A., Middelberg-Bisping, K., Drewes, C. & Schatz, H. Elevated plasma levels of transforming growth factor-β1 in NIDDM. Diabetes Care 19, 1113-1117 (1996). (Pubitemid 26334260)
84. Kon, T. et al. Bone morphogenetic protein 2 stimulates differentiation of cultured spinal ligament cells from patients with ossification of the posterior longitudinal ligament. Calcif. Tissue Int. 60, 291-296 (1997). (Pubitemid 27106255)
85. Tanaka, H. et al. Involvement of bone morphogenic protein 2 (BMP 2) in the pathological ossification process of the spinal ligament. Rheumatology 40, 1163-1168 (2001).
86. Zebboudj, A. F., Imura, M. & Bostrom, K. Matrix GLA protein, a regulatory protein for bone morphogenetic protein 2. J. Biol. Chem. 8, 4388-4394 (2002). (Pubitemid 34968705)
87. Tanno, M., Furukawa, K. I., Ueyama, K., Harata, S. & Motomura, S. Uniaxial cyclic stretch induces osteogenic differentiation and synthesis of bone morphogenetic proteins of spinal ligament cells derived from patients with ossification of the posterior longitudinal ligaments. Bone 33, 475-484 (2003). (Pubitemid 37222373)
88. Ohishi, H. et al. Role of prostaglandin I2 in the gene expression induced by mechanical stress in spinal ligament cells derived from patients with ossification of the posterior longitudinal ligament. J. Pharmacol. Exp. Ther. 305, 818-824 (2003). (Pubitemid 36617956)
89. Iwasawa, T. et al. Pathophysiological role of endothelin in ectopic ossification of human spinal ligaments induced by mechanical stress. Calcif. Tissue Int. 79, 422-430 (2006). (Pubitemid 46020454)
90. Kasperk, C. H. et al. Endothelin 1 is a potent regulator of human bone cell metabolism. Calcif. Tissue Int. 60, 368-374 (1997). (Pubitemid 27143452)
91. Carile, L., Verdone, F., Aiello, A. & Buongusto, G. Diffuse idiopathic skeletal hyperostosis and situs viscerum inversus. J. Rheumatol. 16, 1120-1122 (1989). (Pubitemid 19234743)
92. Smythe, H. A. The mechanical pathogenesis of generalized osteoarthritis. J. Rheumatol. 10 (Suppl. 9), 11-12 (1983). (Pubitemid 14233862)
93. Arlet, J. & Mazieres, B. La maladie hyperostosique. Rev. Mdd. Interne. 6, 553-564 (1985). (Pubitemid 16185643)
94. Mader, R. et al. Developing new classification criteria for diffuse idiopathic skeletal hyperostosis: Back to square one. Rheumatology (Oxford) 52, 326-330 (2013).
95. Olivieri, I. et al. Diffuse idiopathic skeletal hyperostosis: Differentiation from ankylosing spondylitis. Curr. Rheumatol. Rep. 11, 321-328 (2009).
96. Mader, R. Diffuse idiopathic skeletal hyperostosis: Isolated involvement of cervical spine in a young patient. J. Rheumatol. 31, 620-621 (2004). (Pubitemid 38337630)
97. Al-Herz, A., Snip, J. P., Clark, B. & Esdaile, J. M. Exercise therapy for patients with diffuse idiopathic skeletal hyperostosis. Clin. Rheumatol. 27, 207-210 (2008).
98. Troyanovich, S. J. & Buettner, M. A structural chiropractic approach to the management of diffuse idiopathic skeletal hyperostosis. J. Manipulative Physiol. Ther. 26, 202-206 (2003). (Pubitemid 36506199)
99. Roberts, J. A., Tristy, M. & Wolfe, M. A. Chiropractic management of a veteran with lower back pain associated with diffuse idiopathic skeletal hypertrophy and degenerative disk disease. J. Chiropr. Med. 11, 293-299 (2012).
100. El Garf, A. & Khater, R. Diffuse idiopathic skeletal hyperostosis (DISH): A clinicopathological study of the disease pattern in Middle Eastern populations. J. Rheumatol. 11, 804-807 (1984). (Pubitemid 15187513)
101. Hochberg, M. C. et al. American College of Rheumatology recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res. 64, 465-474 (2012).
102. Roth, S. H. & Shainhouse, J. Z. Efficacy and safety of a topical diclofenac solution (pennsaid) in the treatment of primary osteoarthritis of the knee: A randomized, double-blind, vehicle-controlled clinical trial. Arch. Intern. Med. 164, 2017-2023 (2004). (Pubitemid 39390559)
103. Lithell, H. O. L. Effect of antihypertensive drugs on insulin, glucose, and lipid metabolism. Diabetes Care 14, 203-209 (1991).
104. Carlson, M. L., Archibald, D. J., Graner, D. E. & Kasperbauer, J. L. Surgical management of dysphagia and airway obstruction in patients with prominent ventral cervical osteophytes. Dysphagia 26, 34-40 (2011).
105. Urrutia, J. & Bono, C. M. Long-term results of surgical treatment of dysphagia secondary to cervical diffuse idiopathic skeletal hyperostosis. Spine J. 9, e13-e17 (2009).
106. Guillemin, F., Mainard, D., Rolland, H. & Delagoutte, J. P. Antivitamin K prevents heterotopic ossification after hip arthroplasty in diffuse idiopathic skeletal hyperostosis: A retrospective study in 67 patients. Acta Orthop. Scand. 66, 123-126 (1995).
107. Knelles, D. et al. Prevention of heterotopic ossification after total hip replacement: A prospective, randomized study using acetylsalicylic acid, indomethacin and fractional or single-dose irradiation. J. Bone Joint Surg. Br. 79, 596-602 (1997).